acne vulgaris in women who age from 25-
Conditions
Interventions
identical powder tablets,identical active intervention,identical active intervention
placebo,spironolactone 25 mg/day,spironolactone 50 mg/day
Sponsors
Faculty of Medicine, Chulalongkorn University
Eligibility
Sex/Gender
Female
Age
25 Years to 45 Years
Inclusion criteria
Inclusion criteria: healty female with moderate degree acne age from 25-45 years old no underlying hepatic or renal dysfuncions no current topical or systemic medications which can aggrating or suppressing acne condition
Exclusion criteria
Exclusion criteria: patients who are preganacy or lactating. patients who are suspected of polycystic ovarian diseases or other abnormalities predisposing to acne conditions. patients with abnormal skin conditions on their face
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| ration of participants who acheive acne severity score of 0 (clear) or almost clear(1) 3 months acne severity score,rate of adversed event reported 3 months number of events | — |
Secondary
| Measure | Time frame |
|---|---|
| the change of total acne count from baseline 3 months the count of acne | — |
Countries
Thailand
Contacts
Public Contactchanat kumtornrut
chulalongkorn university
Outcome results
None listed